Skip to main content
Figure 2 | BMC Neurology

Figure 2

From: The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis

Figure 2

Pooled relative risk of stroke recurrence,hemorrhagic stroke and all cause death between cilosatzol and aspirin groups insecondary prevention of stroke. (A) Pooled relative risk estimates on recurrence of cerebral infarction. (B) Pooled relative risk estimates on hemorrhage stroke or subarachnoid hemorrhage. (C) Pooled relative risk estimates on all cause death. The diamond indicates the estimated relative risk (95% confidence interval) for all patients together.

Back to article page